Apoliprotein E-mediated ferroptosis controls cellular proliferation in chronic lymphocytic leukemia

Area of Science:

• Hematology
• Molecular Biology
• Cancer Research

Background:

• Chronic lymphocytic leukemia (CLL) exhibits indolence, necessitating research into its molecular vulnerabilities.
• Understanding CLL's molecular basis is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the inhibitory effects of apolipoprotein E (ApoE) on CLL cells.
• To elucidate the molecular mechanisms underlying ApoE-induced CLL cell death.
• To explore ferroptosis as a therapeutic strategy for CLL and Richter syndrome (RS).

Main Methods:

• Treatment of CLL cells with physiological concentrations of ApoE.
• Transcriptomic analysis to identify molecular changes in ApoE-treated CLL cells.
• Investigation of lipid peroxidation, ferroptosis, and copper's role in ApoE toxicity.

Main Results:

• ApoE inhibits CLL cell viability and CD40-driven proliferation.
• ApoE induces lipid peroxidation and ferroptosis in CLL cells, linked to redox and metal imbalance.
• ApoE's toxicity is modulated by intracellular copper; this regulation is often lost in aggressive CLL and RS.
• Aggressive CLL and RS cells remain sensitive to drug-induced ferroptosis.

Conclusions:

• Apolipoprotein E acts as a natural suppressor by inducing ferroptosis in CLL cells.
• Targeting ferroptosis presents a viable therapeutic strategy for both CLL and Richter syndrome.
• Copper dysregulation may contribute to CLL progression and resistance to ApoE.